↓ Skip to main content

Dove Medical Press

Article Metrics

Rituximab in severe skin diseases: target, disease, and dose

Overview of attention for article published in Clinical Pharmacology : Advances and Applications, July 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#29 of 170)
  • High Attention Score compared to outputs of the same age (83rd percentile)

Mentioned by

news
1 news outlet

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
14 Mendeley
Title
Rituximab in severe skin diseases: target, disease, and dose
Published in
Clinical Pharmacology : Advances and Applications, July 2014
DOI 10.2147/cpaa.s10929
Pubmed ID
Authors

Daniel D Bennett, Maro Ohanian, Christian T Cable

Abstract

New clinical indications for rituximab seem to appear every day. This review will trace the use of this monoclonal antibody from lymphoid malignancy, to classic autoimmune disease, and specifically severe autoimmune skin diseases. The history leading to different dosing schema with associated pharmacokinetic data will be discussed. A case of livedoid vasculopathy (atrophie blanche) responding to rituximab will illustrate how the response to therapy can help to elucidate previously obscure pathophysiology.

Mendeley readers

The data shown below were compiled from readership statistics for 14 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 14 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 2 14%
Researcher 2 14%
Student > Bachelor 2 14%
Unspecified 1 7%
Lecturer > Senior Lecturer 1 7%
Other 2 14%
Unknown 4 29%
Readers by discipline Count As %
Medicine and Dentistry 6 43%
Biochemistry, Genetics and Molecular Biology 1 7%
Unspecified 1 7%
Chemistry 1 7%
Agricultural and Biological Sciences 1 7%
Other 0 0%
Unknown 4 29%

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 July 2014.
All research outputs
#3,777,193
of 22,758,248 outputs
Outputs from Clinical Pharmacology : Advances and Applications
#29
of 170 outputs
Outputs of similar age
#37,331
of 225,737 outputs
Outputs of similar age from Clinical Pharmacology : Advances and Applications
#1
of 4 outputs
Altmetric has tracked 22,758,248 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 170 research outputs from this source. They receive a mean Attention Score of 4.9. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 225,737 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them